Stock Market 21 May 2026

Bright Minds Biosciences Up After $220 Piper Sandler Call—Key Level for DRUG Traders
····

Bright Minds Biosciences Up After $220 Piper Sandler Call—Key Level for DRUG Traders

Bright Minds Biosciences shares jumped 11.1% to $82.78 after Piper Sandler raised its price target to $220 and reiterated an “Overweight” rating. The company reported C$309.7 million in cash at March 31, up from C$82.9 million in September, and a wider net loss. Lead drug BMB-101 completed Phase 1 and reported Phase 2 data for epilepsy and absence seizures.
May 21, 2026
Spark I gets Nasdaq notice ahead of Kneron deadline
····

Spark I gets Nasdaq notice ahead of Kneron deadline

Spark I Acquisition Corp disclosed it fell below Nasdaq’s minimum 400-holder requirement, triggering a compliance notice received May 14. Shares closed Wednesday at $12.40, about 8.9% above redemption value, with a $107.37 million market cap. The company has 45 days to submit a compliance plan and is negotiating a merger with Kneron Holding Corporation. Spark reported no revenue and a $94,195 net loss for Q1.
May 21, 2026
Bio-Techne Shares Bounce, Investors Eye a Key Risk
····

Bio-Techne Shares Bounce, Investors Eye a Key Risk

Bio-Techne closed Wednesday at $46.70, up 2.7%, marking a three-day rebound but still 35% below its January high. Fiscal third-quarter revenue fell 2% to $311.4 million, missing Wall Street estimates as weak biotech demand and U.S. academic funding cuts weighed on sales. CEO Kim Kelderman described the academic market as “frail” and not on a clear recovery path. Bio-Techne owns 20% of Wilson Wolf and may acquire the rest.
May 21, 2026
Aterian Moves Lower Pre-Market With $18 Million Ballot Ahead
····

Aterian Moves Lower Pre-Market With $18 Million Ballot Ahead

Aterian shares fell 2.5% to $1.15 in premarket trading Thursday after a May 15 filing showed a wider first-quarter loss and raised “substantial doubt” about its ability to continue. The company is seeking stockholder approval to sell major brands for $18 million and issue $7 million in preferred stock, moves that could give investor David E. Lazar control of over 95% of the company.
May 21, 2026
Vanda Shares Move in Pre-Market Ahead of Nereus and Bysanti Data
····

Vanda Shares Move in Pre-Market Ahead of Nereus and Bysanti Data

Vanda Pharmaceuticals shares fell 0.5% to $6.15 in premarket trading Thursday, trimming part of Wednesday’s 3.2% gain. First-quarter net product sales rose 3% to $51.7 million, but the company posted a $48.6 million net loss and used $50.2 million in operating cash. Vanda raised 2026 revenue guidance to $240–$290 million, expecting Nereus to contribute up to $30 million this year.
May 21, 2026
EHGO Shares Approach 52-Week Lows as Eshallgo Pops Up on Nasdaq Radar Again
····

EHGO Shares Approach 52-Week Lows as Eshallgo Pops Up on Nasdaq Radar Again

EHGO closed at $1.55 on Wednesday, down 4.32%, after hitting a 52-week low of $1.42. The Nasdaq-listed company recently regained compliance with minimum bid rules after a 16-for-1 reverse split. Shareholders approved raising Class B voting rights to 400 votes per share and authorized further share consolidations. Eshallgo’s market value stands near $3.14 million.
May 21, 2026
LIMN Stock Rises in Pre-Market on Liminatus InnocsAI Deal News
····

LIMN Stock Rises in Pre-Market on Liminatus InnocsAI Deal News

Liminatus Pharma agreed to acquire InnocsAI in an all-stock deal, issuing 1.6 billion shares at $0.20 each—over 35 times its current share count. LIMN rose 51% to $0.2844 in premarket trading. The deal would add CAR-T cancer therapy assets, including a candidate authorized for a Phase 1/2a study in South Korea. Liminatus reported $1.91 million in cash and warned of “substantial doubt” about its ability to continue.
May 21, 2026
Cintas Stock Just Lost Its Rebound — Why CTAS Traders Are Watching the UniFirst Deal
····

Cintas Stock Just Lost Its Rebound — Why CTAS Traders Are Watching the UniFirst Deal

Cintas shares closed Wednesday at $171.36, down 0.49%, after giving back gains from a 3.68% jump Monday. The stock lagged the S&P 500, which rose 1.1% the same day. Investors are watching Cintas’ pending $5.5 billion UniFirst acquisition and projected $375 million in cost synergies. Cintas reported fiscal Q3 revenue of $2.84 billion, up 8.9%, and raised its full-year outlook.
May 21, 2026
Aimei Health: Nasdaq Sends AFJK 60-Day Notice
····

Aimei Health: Nasdaq Sends AFJK 60-Day Notice

Aimei Health received a Nasdaq deficiency notice after missing the May 15 deadline for its March-quarter 10-Q filing. Shares traded at $42.18 in pre-market activity ahead of Thursday’s U.S. session. The company has 60 days from the May 19 notice to regain compliance or risk delisting. Aimei is also seeking to complete a merger with United Hydrogen Group, pending regulatory approval.
May 21, 2026
NMFC Stock Moves Higher Ahead of Open as New Mountain Finance Buyback Faces Private Credit Trial
····

NMFC Stock Moves Higher Ahead of Open as New Mountain Finance Buyback Faces Private Credit Trial

New Mountain Finance Corp. closed Wednesday at $8.12, about 26% below its March 31 net asset value of $10.92 per share. The company reported Q1 adjusted net investment income of $32.2 million and declared a 25-cent quarterly distribution. NMFC cut statutory debt-to-equity to 1.12 times and completed a $470 million portfolio sale. Analysts’ average price target stands at $8.54, with most holding a neutral view.
May 21, 2026
AREC Stock Jumps as American Resources’ Rare-Earth Pivot Gets a 10-K Test
····

AREC Stock Jumps as American Resources’ Rare-Earth Pivot Gets a 10-K Test

American Resources Corp filed its delayed 2025 annual report on May 20, showing no revenue for the year and a $17.8 million loss from continuing operations, offset by $73.2 million of income from discontinued operations. Shares last traded flat at $2.14 in Thursday premarket after a 10.3% gain Wednesday. The company reported $31.7 million in cash and a swing to $93.2 million in equity. Disclosure controls remain ineffective due to accounting staff shortages.
May 21, 2026
Flexsteel Faces Key Session After 3.5% Stock Gain
····

Flexsteel Faces Key Session After 3.5% Stock Gain

Flexsteel Industries shares rose 3.5% to close at $55.24 Wednesday ahead of a scheduled investor presentation at Sidoti’s Micro-Cap Virtual Investor Conference on Thursday. The company recently bought back 1,279,870 shares for $60.2 million, reducing its share count by about 24%. Net income for the March quarter was $6.4 million, reversing a year-earlier loss. CEO Derek Schmidt and CFO Mike Ressler will address investors.
May 21, 2026
LivePerson Stock Alert: LPSN Rebounds as SoundHound Deal and Insider Filings Put Shares on Watch
····

LivePerson Stock Alert: LPSN Rebounds as SoundHound Deal and Insider Filings Put Shares on Watch

LivePerson shares closed at $2.07 Wednesday, up 3.0% after Tuesday’s drop. SEC filings showed automatic insider sales by CFO John DeNeen Collins and EVP Monica Greenberg to cover taxes on vested stock awards. The stock’s price remains anchored by SoundHound AI’s pending $43 million acquisition, expected to close in the second half of 2026.
May 21, 2026
First Advantage Stock Pops Again — But Investors Are Still Testing the Earnings Story
····

First Advantage Stock Pops Again — But Investors Are Still Testing the Earnings Story

First Advantage shares closed Wednesday up 2.55% at $15.28 after reporting first-quarter revenue of $385.2 million, an 8.6% increase from a year earlier. Net income reached $2.2 million, reversing a $41.2 million loss. The company maintained its 2026 outlook and repurchased $19.5 million in stock during the quarter. Analyst consensus remains Buy, with an average 12-month target of $18.14.
May 21, 2026
RxSight stock gains ahead of Stifel meeting, investors wait for signs of turnaround
····

RxSight stock gains ahead of Stifel meeting, investors wait for signs of turnaround

RxSight shares closed at $6.16 Wednesday, up 3.53% but still down 40.88% in 2026. First-quarter sales fell 18.5% to $30.9 million, with 27,472 Light Adjustable Lens units and 20 Light Delivery Devices sold. Management will speak at the Stifel Virtual Ophthalmology Forum on May 26. The company kept its 2026 sales outlook at $120 million to $135 million.
May 21, 2026
Star Bulk Stock Gets a Dividend Jolt as SBLK Cash Returns Take Center Stage
····

Star Bulk Stock Gets a Dividend Jolt as SBLK Cash Returns Take Center Stage

Star Bulk Carriers reported first-quarter net profit of $58.5 million, up from $0.5 million a year earlier, and raised its quarterly dividend to $0.50 per share. Shares closed at $26.69, up 2.34%, and held steady in pre-market trade. Voyage revenue rose to $281.2 million. The results follow Diana Shipping’s push to acquire Genco, with Star Bulk set to buy 16 Genco vessels if the deal closes.
May 21, 2026
1 … 17 18 19 20 21 … 127

Stock Market Today

  • London Tube strike disrupts services, hits passenger commute
    June 2, 2026, 3:35 PM EDT. London's Tube network faced major disruption as members of the RMT union struck over proposed 35-hour, four-day driver workweeks. Transport for London (TfL) reported 60% driver attendance, enabling around half of services to run during the morning peak, though usage was down 43%. Several lines were suspended or part-suspended, causing long delays and crowded alternatives. London Mayor Sadiq Khan called for urgent talks to avoid a 24-hour strike planned for Thursday, describing the walkout as a "sign of failure." Passenger reactions varied, with some condemning the timing during exams, while others supported the strike citing safety concerns. Taxi ranks saw heavy demand amid difficult travel conditions.